Notice on Convening the 2025 Annual General Meeting
Filed with SSE · · 6 pages · Chinese
Shanghai Rightongene Biotechnology Co. Ltd. on 6ix
Earlier from Shanghai Rightongene Biotechnology
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Obtaining Government Subsidies
- Earnings Preannouncement for 2025
- Announcement on Using Self-owned Funds to Pay Funds Required for Investment Projects Financed by Raised Funds and Replacing Them with an Equal Amount of Raised Funds
- Notice on Convening the 4th Extraordinary General Meeting in 2025
Later from Shanghai Rightongene Biotechnology
- Report for Q1 2026
- Announcement on Reply to Inquiry Letter for Information Disclosure Supervision of 2025 Annual Report
- Announcement on Convening the 2025 Annual Performance Briefing
- Notice on Convening the 1st Extraordinary General Meeting in 2026
- Announcement on Shareholding Reduction Plan for Shareholders
Follow Shanghai Rightongene Biotechnology into a list and get an email when it puts out news.
Follow Shanghai Rightongene Biotechnology